Table 5 Comorbidities present in vaccinated individuals who died from post-vaccination infections.
From: Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain
Total Deaths | Fully vaccinated before death | Obesity (percent of total deaths per vaccine) | HTN (percent of total deaths per vaccines) | DM (percent of total deaths per vaccines) | CV disease (percent of total deaths per vaccines) | Renal disease (percent of total deaths per vaccine) | Lung disease (percent of total deaths per vaccine) | |
|---|---|---|---|---|---|---|---|---|
Sinopharm | 196 | 125 | 26 (13%) | 120 (61%) | 108 (55%) | 10 (5%) | 30 (15%) | 14 (7%) |
Pfizer-BioNtech | 9 | 3 | 0 | 7 (78%) | 7 (78%) | 0 | 4 (44%) | 0 |
Covishield | 4 | 1 | 1 (25%) | 2 (50%) | 2 (50%) | 0 | 0 | 0 |
Sputnik | 21 | 2 | 2 (9.52%) | 6 (28%) | 5 (24%) | 0 | 0 | 2 (9.5%) |
